Quinuclidine derivatives binding to mucarinic M3 receptors
standard
posted on 2023-06-08, 19:38authored byA G Novartis, Stephen Paul Collingwood, Brian Cox, Urs Baettig, Gurdip Bhalay, Nicholas James Devereux, Novartis Pharma GmbH
Preparation of quinuclidine salts for the treatment of diseases mediated by the muscarinic M3 receptor.